Guidelines for randomized clinical trial protocol content: A systematic review

Systematic Reviews

Volumn 1, Issue 1, 2012, Pages

  Tetzlaff, Jennifer M ^a   Chan, An Wen ^b   Kitchen, Jessica ^b   Sampson, Margaret ^c   Tricco, Andrea C ^d   Moher, David ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Clinical trials; Protocols; Randomized controlled trials; Reporting guideline; SPIRIT initiative; Systematic review

Indexed keywords

ARTICLE; BOOK; CLINICAL PROTOCOL; CLINICAL STUDY; CONTENT VALIDITY; HUMAN; INSTITUTIONAL REVIEW; METHODOLOGY; PRACTICE GUIDELINE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIFIC LITERATURE; SYSTEMATIC REVIEW; REVIEW; STANDARD;

GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

MLCS; MLOWN;

EID: 84871732774     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-1-43     Document Type: Article

References (93)

1. Gluud LL. Bias in clinical intervention research. Am J Epidemiol 2006, 163:493-501. 10.1093/aje/kwj069, 16443796.
2. Bassler D, Ferreira GI, Briel M, Cook DJ, Devereaux PJ, Heels AD, Kirpalani H, Meade MO, Montori VM, Rozenberg A, Schunemann HJ, Guyatt GH. Systematic reviewers neglect bias that results from trials stopped early for benefit. J Clin Epidemiol 2007, 60:869-873. 10.1016/j.jclinepi.2006.12.006, 17689802.
3. Chan A-W, Krleža-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. Can Med Assoc J 2004, 171:735-740.
4. Chan AW, Altman DG. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 2005, 330:753. 10.1136/bmj.38356.424606.8F, 555875, 15681569.
5. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, Decullier E, Easterbrook PJ, von Elm E, Gamble C, Ghersi D, Ioannidis JP, Simes J, Williamson PR. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008, 3:3081.
6. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003, 326:1167-1170. 10.1136/bmj.326.7400.1167, 156458, 12775614.
7. Lancet: Information for authors http://download.thelancet.com/flatcontentassets/authors/lancet-information-for-authors.pdf.
8. British Medical Journal: Resources for authors http://resources.bmj.com/bmj/authors/article-submission/article-requirements.
9. PLoS Medicine: Guidelines for Authors http://journals.plos.org/plosmedicine/guidelines.php.
10. Open Medicine: Author Guidelines http://www.openmedicine.ca/about/submissions#authorGuidelines.
11. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004, 291:2457-2465. 10.1001/jama.291.20.2457, 15161896.
12. Pildal J, Chan AW, Hróbjartsson A, Forfang E, Altman DG, Gøtzsche PC. Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ 2005, 330:1049. 10.1136/bmj.38414.422650.8F, 557221, 15817527.
13. Chan AW, Hróbjartsson A, Jørgensen KJ, Gøtzsche PC, Altman DG. Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols. BMJ 2008, 337:a2299. 10.1136/bmj.a2299, 2600604, 19056791.
14. Gøtzsche P, Hróbjartsson A, Johansen H, Haahr M, Altman D, Chan A. Ghost authorship in industry-initiated randomised trials. PLoS Med 2007, 4:e19. 10.1371/journal.pmed.0040019, 1769411, 17227134.
15. Hernández AV, Steyerberg EW, Taylor GS, Marmarou A, Habbema JD, Maas AI. Subgroup analysis and covariate adjustment in randomized clinical trials of traumatic brain injury: a systematic review. Neurosurgery 2005, 57:1244-1253.
16. Chan A-W. Bias, spin, and misreporting: Time for full access to trial protocols and results. PLoS Med 2008, 5:e230. 10.1371/journal.pmed.0050230, 2586359, 19067481.
17. Chan A-W. Access to clinical trial data. BMJ 2011, 342:d80. 10.1136/bmj.d80, 21228020.
18. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marušiæ A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB, International Committee of Medical Journal Editors Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Croat Med J 2004, 45:531-532. International Committee of Medical Journal Editors.
19. Equator Network: Enhancing the QUAlity and Transparency Of health Research http://www.equator-network.org.
20. Simera I, Altman DG, Moher D, Schulz KF, Hoey J. Guidelines for reporting health research: the EQUATOR network's survey of guideline authors. PLoS Med 2008, 5:e139. 10.1371/journal.pmed.0050139, 2443184, 18578566.
21. Campbell MK, Elbourne DR, Altman DG, CONSORT group CONSORT statement: extension to cluster randomised trials. BMJ 2004, 328:702-708. 10.1136/bmj.328.7441.702, 381234, 15031246, CONSORT group.
22. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008, 337:1223-1226.
23. Boutron I, Moher D, Altman DG, Schulz K, Ravaud P, for the CONSORT group Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med 2008, 148:W60-W66. for the CONSORT group.
24. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006, 144:364-367.
25. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group Preferred Reporting Items for Systematic reviews and Meta-Analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097. 10.1371/journal.pmed.1000097, 2707599, 19621072, The PRISMA Group.
26. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370:1453-1457. 10.1016/S0140-6736(07)61602-X, 18064739.
27. Schulz KF, Altman DG, Moher D, CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010, 7:e1000251. 10.1371/journal.pmed.1000251, 2844794, 20352064, CONSORT Group.
28. Turner L, Moher D, Shamseer L, Weeks L, Peters J, Plint A, Altman DG, Schulz KF. The influence of CONSORT on the quality of reporting of randomised controlled trials: an updated review. Trials 2011, 12(Suppl 1):A47.
29. Smidt N, Rutjes AW, van der Windt DA, Ostelo RW, Bossuyt PM, Reitsma JB, Bouter LM, de Vet HC. The quality of diagnostic accuracy studies since the STARD statement: has it improved?. Neurology 2006, 67:792-797. 10.1212/01.wnl.0000238386.41398.30, 16966539.
30. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 2006, 185:263-267.
31. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med 2009, 7:e1000217.
32. Sampson M, McGowan J, Cogo E, Horsley T. Managing database overlap in systematic reviews using Batch Citation Matcher: case studies using Scopus. J Med Libr Assoc 2006, 94:461463.
33. Amazon http://www.Amazon.com.
34. WorldCat www.WorldCat.org.
35. Paraje G, Sadana R, Karam G. Public health. Increasing international gaps in health-related publications. Science 2005, 308:959-960. 10.1126/science.1108705, 15890863.
36. Clinical Data Interchange Standards Consortium (CDISC) Protocol Representation Model http://www.cdisc.org/protocol, Clinical Data Interchange Standards Consortium (CDISC).
37. Spilker B. Guide to clinical studies and developing protocols 1984, New York: Raven.
38. Spilker B. Guide to clinical trials 1991, New York: Raven.
39. Working group of the Commission on Dental Materials IEaT Recommendation plan for research protocol. FDI Commission on Dental Products, Instruments, Equipment and Therapeutic Agents (COMIET), G.T. Clinical trials. The French version: INCOGUDET]. Int Dent J 1977, 27:299-300. Working group of the Commission on Dental Materials IEaT.
40. Working group of the Commission on Dental Materials IEaT Recommended outline for a research protocol. Prepared by a working group of the Commission on Dental Materials, Instruments, Equipment and Therapeutics. Int Dent J 1977, 27:44-45. Working group of the Commission on Dental Materials IEaT.
41. Council for International Organizations of Medical Sciences International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics 2002, 182:17-23. Council for International Organizations of Medical Sciences.
42. Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO) International Ethical Guidelines for Biomedical Research Involving Human Subjects 2002, Geneva: Council for International Organizations of Medical Sciences (CIOMS), Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO).
43. Detailed guidelines on the principles of good clinical practice in the conduct in the European Union of clinical trials on medicinal products for human use Ver 5.1 http://ec.europa.eu/health/files/pharmacos/docs/doc2002/july/gcp_51_july_en.pdf.
44. NHS Department of Health [UK] Clinical trials toolkit http://www.ct-toolkit.ac.uk/_db/_documents/Protocol.pdf, NHS Department of Health [UK].
45. Akl EA, Treweek S, Foy R, Francis J, Oxman AD. NorthStar, a support tool for the design and evaluation of quality improvement interventions in healthcare. Implement Sci 2007, 2:19. 10.1186/1748-5908-2-19, 1913538, 17594495.
46. Treweek S, McCormack K, Abalos E, Campbell M, Ramsay C, Zwarenstein M, PRACTIHC C. The Trial Protocol Tool: The PRACTIHC software tool that supported the writing of protocols for pragmatic randomized controlled trials. J Clin Epidemiol 2006, 59:1127-1133. 10.1016/j.jclinepi.2005.12.019, 17027422.
47. Betkerur J. Guidelines for writing a research project synopsis or protocol. Indian J Dermatol Venereol Leprol 2008, 74:687-690. 10.4103/0378-6323.45136, 19172017.
48. World Health Organization Health research methodology: A guide for training in research methods 2001, Manila: World Health Organization, Regional Office for the Western Pacific, World Health Organization.
49. Indrayan A. Elements of medical research. Indian J Med Res 2004, 119:93-100.
50. Girling DJ. Important issues in planning and conducting multi-centre randomised trials in cancer and publishing their results. Crit Rev Oncol Hematol 2000, 36:13-25. 10.1016/S1040-8428(00)00095-0, 10996520.
51. Ivanov A, Van GM. Design, management and handling of a randomized trial. [French]. Bull Cancer 1995, Suppl 5:553s-557s.
52. Moorhead JE, Rao PV, Anusavice KJ. Guidelines for experimental studies. Dent Mater 1994, 10:45-51. 10.1016/0109-5641(94)90021-3, 7995475.
53. Staquet M, Sylvester R, Jasmin C. Guidelines for the preparation of E.R.T.C. cancer clinical trial protocols. Eur J of Cancer (Oxford) 1980, 16:871-875.
54. Warren MD. Aide-memoire for preparing a protocol. Br Med J 1978, 1:1195-1196. 10.1136/bmj.1.6121.1195, 1604243, 638692.
55. de Saintonge CD. Aide-memoire for preparing clinical trial protocols. Br Med J 1977, 1:1323-1324. 1607199, 861601.
56. Malhotra S, Shafiq N, Pandhi P. A method for rapid, objective and structured evaluation (ROSE) of protocol of a randomised clinical trial. Bull, Postgrad Inst Med Ed Res, Chandigarh 2005, 39:22-26.
57. Piantadosi S. Clinical trials: a methodologic perspective 2005, Hoboken, N.J: Wiley-Interscience.
58. Pocock SJ. Clinical trials: a practical approach 1983, New York: John Wiley and Sons Ltd, Chichester.
59. Bridge H, Smolskis M, Bianchine P, Dixon DO, Kelly G, Herpin B, Tavel J, Protocol Template Working Group of the NIAID Clinical Research Subcommittee Development and implementation of clinical trial protocol templates at the National Institute of Allergy and Infectious Diseases. Clin 2009, 6:386-391. Protocol Template Working Group of the NIAID Clinical Research Subcommittee.
60. Laurencot CM, Ruppel S. Regulatory aspects for translating gene therapy research into the clinic. Methods Mol Biol 2009, 542:397-421.
61. O'Dowd T, Jones S. Protocols: getting them right. Practitioner 1988, 232:713-714.
62. Blandford DH, Warren GB, Campbell EM. Uses and content of a research protocol. J Dent Educ 1984, 48:298-301.
63. British Medical Association, Royal College of General Practitioners and Association of the British Pharmaceutical Industry Code of practice for the clinical assessment of licensed medicinal products in general practice. Br Med J (Clin Res Ed) 1983, 286:1295-1297. British Medical Association, Royal College of General Practitioners and Association of the British Pharmaceutical Industry.
64. Souche A, Zekri J-R, Thermoz P. Therapeutic tests of the medicins a clinical protocol established on priority why?. Psychologie Medicale 1990, 22:1483-1484.
65. Pignon JP, Doyon F. Randomized clinical trials. Part I. Principles, protocol and organization. Reanim Soins Intensifs Med D'Urgence 1989, 5:239-243.
66. Schneidermann M. Controlled clinical trials: Monday's count-down for Tuesday's launching. J New Drugs 1961, 1:250-255.
67. Bordage G, Dawson B. Experimental study design and grant writing in eight steps and 28 questions. Med Educ 2003, 37:376-385. 10.1046/j.1365-2923.2003.01468.x, 12654123.
68. Williams AM. Neuroscience nursing: designing the research proposal. J Neurosci Nurs 1989, 21:389-391. 10.1097/01376517-198912000-00015, 2532675.
69. Centers for Disease Control and Prevention Developing a protocol: a guide for CDC investigators http://www.umdnj.edu/hsweb/Forms/Forms_Developing_a_Protocol.pdf, Centers for Disease Control and Prevention.
70. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 http://www.ich.org/cache/compo/276-254-1.html.
71. A Standard for the Scientific and Ethical Review of Trials (ASSERT) Statement http://www.assert-statement.org/explandoc.pdf.
72. U.S. Department of Health and Human Services Public Health Service Grant Application (PHS 398) Part I and Part II. OMB No. 0925-0001 http://grants.nih.gov/grants/funding/phs398/phs398.html, U.S. Department of Health and Human Services.
73. Merck investigator studies program (MISP) Protocol template. Requirements for submitting a full proposal http://merckresearch.net/doc/MISP%20Protocol%20Template.doc, Merck investigator studies program (MISP).
74. Investigator-initiated research (IIR) & requests for pure substance (CTP) http://media.pfizer.com/files/research/iir_information.pdf, 1068908, 3081467.
75. Funding opportunity details http://www.cihr-irsc.gc.ca/e/39187.html.
76. Schwartz D, Flamant R, Lellouch J. Clinical trials 1980, New York - London: Academic.
77. Eschwège E, Bouvenot G, Doyon F, Lacroux A. Essais thérapeutiques: mode d'emploi 1990, Paris, France: Inserm.
78. Bowling A. Research methods in health: investigating health and health services 2002, Buckingham - Philadelphia: Open University Press.
79. Ahmed AM. A guide for writing a protocol for a clinical trial. Sudan J Public Health 2010, 5:23-28.
80. Wellcome Trust: Funding for clinical trials. Requirements for applicants http://www.wellcome.ac.uk/Funding/Biomedical-science/Application-information/WTX022708.htm.
81. Programm klinische studien leitfaden für die antragstellung http://www.gesundheitsforschung-bmbf.de/_media/Leitfaden_Klinische_Studien_100818.pdf.
82. Food and Drug Administration Code of Federal Regulations: Food and Drugs 2002, 21CFR312.23, Food and Drug Administration.
83. Moher D, Weeks L, Ocampo M, Seely D, Sampson M, Altman DG, Schulz KF, Miller DL, Simera I, Grimshaw J, Hoey J. Describing reporting guidelines for health research: a systematic review. J Clin Epidemiol 2011, 64:718-742. 10.1016/j.jclinepi.2010.09.013, 21216130.
84. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008, 336:601-605. 10.1136/bmj.39465.451748.AD, 2267990, 18316340.
85. Odgaard-Jensen J, Vist GE, Timmer A, Kunz R, Akl EA, Schünemann H, Briel M, Nordmann AJ, Pregno S, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 2011, MR000012.
86. Pildal J, Hróbjartsson A, Jørgensen KJ, Hilden J, Altman DG, Gøtzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 2007, 36:847-857. 10.1093/ije/dym087, 17517809.
87. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects http://www.wma.net/en/30publications/10policies/b3/index.html.
88. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003, 289:454-465. 10.1001/jama.289.4.454, 12533125.
89. Kjaergard LL, Is-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 2002, 325:249. 10.1136/bmj.325.7358.249, 117638, 12153921.
90. Fergusson D, Glass KC, Hutton B, Shapiro S. Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?. Clin 2005, 2:218-229.
91. Puhan MA, Vollenweider D, Steurer J, Bossuyt PM, ter Riet G. Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review. BMC Med 2008, 6:28. 10.1186/1741-7015-6-28, 2569060, 18847478.
92. Oxman AD, Fretheim A, Schunemann HJ, Haines A, Langer A, Pang T, Panisset U, Whitworth J. Improving the use of research evidence in guideline development: Introduction. Health Res Pol Syst 2006, 2006:4.
93. Editorial Strengthening the credibility of clinical research. Lancet 2011, 375:1226. Editorial.